Toremifene: Clinical Trials

6 trials of Toremifene, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6

Follow Toremifene: new trials by email Literature Review of Toremifene trials Research Report on Toremifene

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Changes in Breast 3D Ultrasound Measurements Using Toremifene
Toremifene - Circulatory; Change
Phase 3CompletedSatakunta Central Hospital202010-09-012011-08-23
The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia
toremifene, placebo - Breast Pain
Phase 3CompletedSatakunta Central Hospital102007-04-012009-05-13
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
Toremifene 20 mg, Placebo - Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia
Phase 3CompletedGTx15892005-01-012023-06-12
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
Toremifene Citrate - Prostate Cancer, Osteoporosis
Phase 3CompletedGTx12002003-10-012013-11-15
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
atamestane, toremifene, letrozole - Breast Neoplasms, Neoplasms, Hormone-dependent
Phase 3CompletedIntarcia Therapeutics8652002-06-012015-07-31
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride - Breast Cancer
Phase 3CompletedETOP IBCSG Partners Foundation4521993-05-012013-04-04

Conditions studied

Breast Neoplasms (2)  ·  Bone Diseases, Metabolic (1)  ·  Carcinoma, Ductal, Breast (1)  ·  Carcinoma, Lobular (1)  ·  Fractures, Bone (1)  ·  Mastodynia (1)  ·  Neoplasms (1)  ·  Neoplasms, Hormone-Dependent (1)  ·  Osteoporosis (1)  ·  Precancerous Conditions (1)  ·  Premenstrual Syndrome (1)  ·  Prostatic Intraepithelial Neoplasia (1)  ·  Prostatic Neoplasms (1)

Sponsors

GTx (2)  ·  Satakunta Central Hospital (2)  ·  ETOP IBCSG Partners Foundation (1)  ·  Intarcia Therapeutics (1)

Countries

United States (3)  ·  Canada (2)  ·  Finland (2)  ·  Argentina (1)  ·  Australia (1)  ·  Italy (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Slovenia (1)  ·  South Africa (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Ukraine (1)

Top investigators

Edda Simoncini, MD (1)  ·  Mitchell Steiner, M.D. (1)  ·  Paul Goss, M.D. (1)  ·  Samir Taneja, MD (1)  ·  Sinikka Oksa, MD (1)

Results publications

PMID 22245322, PMID 23234631, PMID 23295793